Patents by Inventor Christopher Benyon

Christopher Benyon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for liver disease
    Publication number: 20080220056
    Abstract: The present invention is based on the finding that the artificial induction of hepatic stellate cell (HSC) apoptosis in vivo can promote the resolution of liver fibrosis. Thus, the present invention provides methods for treating liver disease in a subject involving administration of an inducer of apoptosis which is capable of selectively inducing hepatic stellate cell apoptosis in the liver of the subject or of an agent which is capable of giving rise to such an inducer in the subject. In addition, the invention provides methods for treating liver fibrosis in a subject comprising the selective delivery of an inducer of apoptosis specifically to the hepatic stellate cells of the subject or of an agent which is capable of giving rise to an inducer of hepatic stellate cell apoptosis.
    Type: Application
    Filed: May 21, 2007
    Publication date: September 11, 2008
    Applicant: UNIVERSITY OF SOUTHAMPTON
    Inventors: Michael James Paul Arthur, Derek Austin Mann, John Peter Iredale, Christopher Benyon, Frank Murphy, Fiona Oakley, Richard Ruddell, Matthew Christopher Wright
  • Treatment for liver disease
    Publication number: 20050191302
    Abstract: The present invention is based on the finding that the artificial induction of hepatic stellate cell (HSC) apoptosis in vivo can promote the resolution of liver fibrosis. Thus, the present invention provides methods for treating liver disease in a subject involving administration of an inducer of apoptosis which is capable of selectively inducing hepatic stellate cell apoptosis in the liver of the subject or of an agent which is capable of giving rise to such an inducer in the subject. In addition, the invention provides methods for treating liver fibrosis in a subject comprising the selective delivery of an inducer of apoptosis specifically to the hepatic stellate cells of the subject or of an agent which is capable of giving rise to an inducer of hepatic stellate cell apoptosis.
    Type: Application
    Filed: August 28, 2003
    Publication date: September 1, 2005
    Applicant: UNIVERSITY OF SOUTHAMPTON
    Inventors: Michael Arthur, Derek Mann, John Iredale, Christopher Benyon, Frank Murphy, Fiona Oakley, Richard Ruddell, Matthew Wright